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Synthesis of acyclic nucleoside analogues 
by one-step Vorbrüggen glyco-sylation 
of 1,2,4-triazolo[1,5-a]pyrimidine-7-ones
New analogues of acyclovir have been prepared by reacting 1,2,4 
-triazolo[1,5-a]pyrimidin-7-ones 1а-i and (2-acetoxyethoxy)methyl acetate 
2 in the presence of trimethylsilyl trifluoromethanesulfonate as a catalyst. The 
interaction between the compounds 1а-е and 2 has led to a mixture of N3 
and N4 isomers. In contrast, the reaction of compounds 1g-i and 2 proceeded 
selectively to form N3 isomers. In the case of compounds 1a-c the predominant 
product is the one with the acyclic moiety in azine ring (N4 isomer). Interaction 
between 1d-f and 2 has led to mixtures comprising mainly N3 isomer. It has 
been found that the ratio of glycosylation products 1 and 2 are thermodynami-
cally controlled. The structure of the obtained compounds has been proved by 
1Н, 13С, two-dimensional 1Н-13С NMR spectroscopy and X-ray analysis.
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1,2,4-Triazolo[1,5-a]pyrimi-
dines derivatives are the basis of many 
biologically active compounds1,2, and 
their N-substituted derivatives can be 
used to create antiviral and antitumor 
compounds3,4. Considering that the thera-
peutic potential of nucleoside analogues 
based on 1,2,4-triazolo[1,5-a]pyrimidine-
7-ones, the development of effective syn-
thetic procedures has become an actual 
task. As a continuation of our studies in 
the search for new inhibitors of the rep-
lication of herpes simplex virus, we have 
synthesized a series of new acyclic  nu-
cleoside analogues 3a-i and 4a-f on the 
basis of 1,2,4-triazolo[1,5-a]pyrimidines.
Reaction of 1,2,4-triazolo[1,5-a]pyrimi-
dine-7-ones 1a-i with (2-acetoxyethoxy) 
methyl acetate in the presence of tri-
methylsilyl trifluoromethane sulphonate 
as a catalyst resulted in alkylated prod-
ucts 3 and 4. In the case of compounds 
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1a-c in the reaction mixture, N3 deriva-
tives of 3a-c usually predominate. In the 
case of compounds 1d-f, conditions for 
selectively produce both N3 and N4 de-
rivatives have been chosen. 1g-i gives 
only N3 alkylated products 3g-I (Table 1). 
The structure of 3a-i and 4a-f was defined 
on the basis of two-dimensional 1H-13C 
HMBC NMR experiments.
Table 1
Yield, ratio of isomers of acyclic nucleoside analogues
Yield, 
correlation of 
Heterocycle
R1 R2 R3 Metoda Ratiob Yield (%)
1a H H Me
A 62:38 56
В 100:0 60
1b Me H Me
А 51:49 59
B 75:25 49
1c SMe H Me
А 52:48 63
B 94:6 80
1d H Ph H
A 5:95 86
B 75:25 48
1e Me Ph H
A 40:60 70
B 70:30 43
1f SMe Ph H
A 4:96 59
B 60:40 46
1g H H Ph
A 100:0 39
B 100:0 41
1h Me H Ph
A 100:0 75
B 100:0 24
1i SMe H Ph
A 100:0 35
B 100:0 34
a Conditions A: MeCN (7 mL), BSA (2 mmol), 1a-i (1.8 mmol), TMSOTf (2 mmol), 0.5ch; 
B: MeCN (7 mL), 1a-i (1.8 mmol), TMSOTf (2 mmol) 0.2ch; b The 3:4 ratio was determined 
by 1H NMR.
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Compounds 3a-I have been character-
ized by presence of cross peaks between 
the protone signals at C1’ atom, and C2 
and C3a carbon atoms. In the case of 4a-f 
derivatives, N4 position of acyclic frag-
ment is confirmed by a cross peak be-
tween C5 and H1' atoms. Furthermore, 
for crystals of the 3d and 4d compounds 
X-ray diffraction analysis has been per-
formed, which is fully consistent with 
NMR data.
Deprotection of the substances 3a-i 
and 4a-f under the action of a metha-
nolic solution of ammonia has led to 
novel acyclovir analogues 5a-i and 6a-f. 
The cytotoxicity and antiviral activity of 
compounds 5a-i and 6a-f have been in-
vestigated against herpes simplex virus 
type I in Vero cells in accordance with the 
procedure [3]. The obtained compounds 
showed weaker activity against HSV 
compared to acyclovir.
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